The English Football Association has imposed a four-year ban on Chelsea winger Mykhailo Mudryk following an 18-month anti-doping investigation that concluded on 29 April 2026. The punishment represents the maximum sanction available under the FA’s Anti-Doping Regulations and effectively sidelines the 25-year-old from professional football until late 2028 if upheld.
Mudryk returned a positive test for meldonium — a cardiovascular medication classified as a prohibited substance — during a routine urine screening conducted while on international duty with the Ukraine national team in October 2024. Meldonium is known to artificially enhance respiratory capacity and stamina. According to the FA’s official findings, the Ukrainian breached Regulations 3 and 4 of their Anti-Doping Regulations concerning the presence and use of a prohibited substance.
The winger was first hit with a provisional suspension in December 2024, before being formally charged in June 2025. His last competitive appearance predates that provisional ban, with his final match having taken place in November 2024. Since then, Mudryk has been barred from Chelsea’s Cobham training facility and has been maintaining his fitness by working with a private coach and hired goalkeepers at non-league club Uxbridge FC.
The ban has already produced notable off-field moments. Unable to train with his club, Mudryk travelled independently to Wrocław last May to watch Chelsea secure the 2024/2025 UEFA Conference League title against Real Betis — a trophy won without him playing any part in the campaign.
From the outset, the player has firmly contested the allegations. He described the failed test as a “complete shock” and has stated he had “never knowingly used any banned substances.” His legal representatives at Morgan Sports Law filed a formal appeal with the Court of Arbitration for Sport (CAS) on 25 February 2026. Both parties are currently exchanging written submissions ahead of a scheduled hearing, with the Switzerland-based court yet to issue a ruling.
Mudryk joined Chelsea in the January 2023 transfer window from Shakhtar Donetsk in a deal worth a reported £89 million on a contract spanning eight and a half years, making him one of the club’s most significant recent acquisitions. His time at Stamford Bridge had already been marked by inconsistent form and limited first-team impact before the doping case emerged.
The meldonium substance gained widespread attention following the suspension of Russian tennis player Maria Sharapova in 2016 after she also tested positive for the drug. The World Anti-Doping Agency (WADA) added meldonium to its prohibited list in January 2016. Several athletes in that period cited lack of awareness of the ban as a mitigating factor, though regulators have consistently maintained that ignorance of prohibited substance classifications is not a valid defence.
Should CAS overturn the FA’s decision, Mudryk could return to professional football significantly earlier. However, if the appeal fails and the four-year ban is confirmed, the forward will not be eligible to resume his career until the latter stages of the 2028 calendar year, by which point he will be 27 years old. The outcome of the CAS hearing is expected to have significant contractual and financial implications for both the player and Chelsea Football Club.
